NextGen Jane: Funding, Investors & Team (Sep 2026)
NextGen Jane is a data-driven women's health company offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease. The company's smart tampon platform allows users to conveniently mail-in cells from the reproductive tract that are shed during menstruation. It focuses on developing tests based on a patented tampon collection technology. NextGen Jane was founded in 2014 and is headquartered in Oakland, California, United States.
NextGen Jane has raised $10.7M across 3 funding rounds on record, the most recent an undisclosed round of $2.2M announced in May 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NextGen Jane Company Profile and Key Stats
Latest funding round on record: May 2025.
NextGen Jane Funding Rounds
NextGen Jane raised $1.5M in a Grant announced in Feb 2022.
1.7 years later, an undisclosed round of $7.0M was announced in Oct 2023.
1.6 years later, an undisclosed round of $2.2M was announced in May 2025.
NextGen Jane Founders and Leadership Team
Contact details for the NextGen Jane team: 2 of 2 have an email address on file.
Start 14-day free trial →NextGen Jane Funding Compared to Other Biotechnology Startups
NextGen Jane's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NextGen Jane in Biotechnology and Oakland
Companies Similar to NextGen Jane
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
NextGen Jane Funding FAQs
What does NextGen Jane do?
NextGen Jane is a data-driven women's health company offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease. The company's smart tampon platform allows users to conveniently mail-in cells from the reproductive tract that are shed during menstruation. It focuses on developing tests based on a patented tampon collection technology. NextGen Jane was founded in 2014 and is headquartered in Oakland, California, United States.
How much funding has NextGen Jane raised?
NextGen Jane has raised $10.7M across 3 rounds on record. The most recent is an undisclosed round of $2.2M announced in May 2025.
When did NextGen Jane last raise funding?
NextGen Jane's most recent funding round on record is an undisclosed round of $2.2M, announced in May 2025.
Who founded NextGen Jane?
FundedIQ lists Stephen Gire (Founder) at NextGen Jane.
Who is the CEO of NextGen Jane?
Ridhi Tariyal is listed as CEO at NextGen Jane.
Where is NextGen Jane headquartered?
NextGen Jane is based in Oakland, California, United States.
How many employees does NextGen Jane have?
NextGen Jane is in the 1-10 employee band.
How does NextGen Jane's funding compare to other Biotechnology startups?
NextGen Jane's latest round of $2.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NextGen Jane Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NextGen Jane is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.